StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3048% below fair value
$143.82−4.00 (-2.71%)

Close on Nov 20, 2026Market cap $19.26BP/E 7.5Yield –

Alnylam Pharmaceuticals Depreciation and Amortization by Quarter

Depreciation and Amortization ($M)

Alnylam Pharmaceuticals Depreciation and Amortization: $14.5M in Q3 2026, up 5.1% from a year earlier.

Latest, Q3 2026
14.5
Period ended Sep 30, 2026
Change on a year earlier
+5.1%
13.8 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
38
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Alnylam Form 10-Q (filed 2026-10-29) ↗

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDepreciation and Amortization ($M)Year on yearSource
Q3 2026Sep 30, 202614.5+5.1%Alnylam Form 10-Q (filed 2026-10-29) ↗
Q2 2026Jun 30, 202613.90.0%Alnylam Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 202613.6-5.6%Alnylam Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 202513.5-4.9%Alnylam Form 10-K (filed 2026-02-12) ↗
Q3 2025Sep 30, 202513.8-1.4%Alnylam Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 202513.9-7.3%Alnylam Form 10-Q (filed 2025-07-31) ↗
Q1 2025Mar 31, 202514.4+6.7%Alnylam Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 202414.2+5.2%Alnylam Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 202414+5.3%Alnylam Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 202415+13.6%Alnylam Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 202413.5-4.3%Alnylam Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 202313.5-5.6%Alnylam Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 202313.3+25.5%Alnylam Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 202313.2+30.7%Alnylam Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 202314.1+48.4%Alnylam Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 202214.3+25.4%Alnylam Form 10-K (filed 2023-02-23) ↗

Cite this data

StockData. (2026). Alnylam Pharmaceuticals Depreciation and Amortization ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Alnylam Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/alny/kpis/db-da-cf

See every metric in the Alnylam Pharmaceuticals KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?